Crossmark

Circulating cytokines and inflammatory indices associate with prognosis and toxicities in first line extensive stage small cell lung cancer immunochemotherapy

Crossref DOI link: https://doi.org/10.1038/s41598-026-73234-y

Published Online: 2026-10-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Xu, Ziwei

Gao, Yongfeng

Zhou, Ling

Zeng, Ran

Hu, Xiaoyan

Shen, Xiang

Feng, Xiangran

Lyu, Mengchen

Bao, Zhiyao

Sun, Xianwen

Gao, Beili

Li, Yong

Cheng, Qijian

Chen, Xiaoyan

Xiang, Yi https://orcid.org/0000-0002-0724-6359
Funding

Funding for this research was provided by:

Wu Jieping Medical Foundation (Grant No. 3206750.20230591)
License Information

Text and Data Mining valid from 2026-10-07

Accepted Manuscript valid from 2026-10-07
More Information

Article History

Received: 23 February 2026

Accepted: 22 September 2026

First Online: 7 October 2026

Declarations

Competing interests: The authors declare no competing interests.

Document is current

Any future updates will be listed below